Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
Crown Electrokinetics Corp. (CRKN) stock has hit a distressing 52-week low, dropping to $4.26, as the company faces severe market headwinds. According to InvestingPro analysis, the company’s market capitalization has contracted to just $1.82 million, though technical indicators suggest the stock is currently in oversold territory. This latest price level reflects a staggering 1-year change, with the stock value plummeting by -99.81%. Investors are grappling with the stark reality of this significant downturn, as the company’s shares struggle to regain lost ground in a challenging economic environment. Despite the current challenges, analysts project significant revenue growth of 811% this year, and the stock appears undervalued based on comprehensive Fair Value analysis available through InvestingPro’s detailed research reports.
In other recent news, Crown Electrokinetics Corp. announced a 1-for-150 reverse stock split of its common stock, effective January 30, 2025. This strategic move aims to consolidate shares to maintain the company’s Nasdaq listing, which Crown’s CEO, Doug Croxall, considers vital for the company’s growth and credibility. Despite the reverse split, Crown maintains a healthy cash balance exceeding $25 million and is experiencing growing revenues. The company also recently expanded its team, welcoming Andy Mayer and his expertise in disaster rehabilitation and pipeline industries. In another development, Crown Electrokinetics received a notification from Nasdaq about non-compliance with the exchange’s minimum bid price requirement. The company has been under a Mandatory Panel Monitor since July 25, 2024, and due to multiple reverse stock splits, it is ineligible for a compliance period under Nasdaq rules. Crown plans to request a hearing before the Nasdaq Hearings Panel to delay any delisting actions, although there is no certainty of continued listing. The company’s stock will continue trading on the Nasdaq under the ticker "CRKN" during this process.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.